SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024313
Filing Date
2020-05-11
Accepted
2020-05-11 16:53:02
Documents
57
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q umrx-10q_20200331.htm 10-Q 1169605
2 EX-10.3 umrx-ex103_142.htm EX-10.3 77338
3 EX-31.1 umrx-ex311_124.htm EX-31.1 10010
4 EX-31.2 umrx-ex312_123.htm EX-31.2 9939
5 EX-32.1 umrx-ex321_121.htm EX-32.1 6213
6 EX-32.2 umrx-ex322_122.htm EX-32.2 5942
  Complete submission text file 0001564590-20-024313.txt   3855898

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT umrx-20200331.xml EX-101.INS 555457
8 XBRL TAXONOMY EXTENSION SCHEMA umrx-20200331.xsd EX-101.SCH 39997
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE umrx-20200331_cal.xml EX-101.CAL 30850
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE umrx-20200331_def.xml EX-101.DEF 119477
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE umrx-20200331_lab.xml EX-101.LAB 301316
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE umrx-20200331_pre.xml EX-101.PRE 226097
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 20865717
SIC: 2834 Pharmaceutical Preparations